Andrew G Bert

Author PubWeight™ 47.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008 24.27
2 A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008 7.45
3 MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 2008 4.81
4 An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell 2011 2.49
5 The microRNA-200 family regulates epithelial to mesenchymal transition. ScientificWorldJournal 2008 1.44
6 Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. Neoplasia 2013 1.25
7 Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state. J Cell Sci 2013 1.24
8 Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization. Mol Cell Biol 2004 1.21
9 Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition. J Biol Chem 2014 0.94
10 Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3beta and repression of the human VEGF promoter. FEBS Lett 2005 0.94
11 Identification of an enhancer that increases miR-200b~200a~429 gene expression in breast cancer cells. PLoS One 2013 0.82
12 Transcription-dependent silencing of inducible convergent transgenes in transgenic mice. Epigenetics Chromatin 2010 0.82
13 Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1. Leuk Res 2010 0.79
14 The inducible tissue-specific expression of the human IL-3/GM-CSF locus is controlled by a complex array of developmentally regulated enhancers. J Immunol 2012 0.77